The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
Outcome measures in chronic obstructive pulmonary disease (COPD): strengths and limitations
Open accessAbstract
Current methods for assessing clinical outcomes in COPD mainly rely on physiological tests combined with the use of questionnaires. The present review considers commonly used outcome measures such as lung function, health status, exercise capacity and physical activity, dyspnoea, exacerbations, the multi-dimensional BODE score, and mortality. Based on current published data, we provide a concise overview of the principles, strengths and weaknesses, and discuss open questions related to each methodology. Reviewed is the current set of markers for measuring clinically relevant outcomes with particular emphasis on their limitations and opportunities that should be recognized when assessing and interpreting their use in clinical trials of COPD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although neither group achieved the minimum clinically important difference of 4 points”
From Cognitive behavioral therapy for management of dyspnea: A pilot study (2015) · cites this paper as [33]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“both achieved the lower range of changes considered clinically meaningful (change between 2 and 8 points 33 )”
From Cognitive behavioral therapy for management of dyspnea: A pilot study (2015) · cites this paper as [33]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Psychophysical bases of perceived exertion
BORG, G. A. V. (1982) · Medicine & Science in Sports & Exercise · doi:10.1249/00005768-198205000-00012 · Cited by 16,580 · cited 1×
“Borg-Scale (CR-10) The CR-10 or Borg-Scale has been developed primarily as an objective tool to measure exertional dyspnoea in COPD patients [50,51].”
MethodVestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
Self-citationMiller, M. R., Hankinson, J., Brusasco, V., Burgos, F., Casaburi, R., Coates, A., Crapo, R., Enright, P., van der Grinten, C. P. M., Gustafsson, P., et al. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00034805 · Cited by 15,627
ATS Statement: Guidelines for the Six-Minute Walk Test
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.166.1.at1102 · Cited by 11,195
Interpretative strategies for lung function tests
Pellegrino, R., Viegi, G., Brusasco, V., Crapo, R. O., Burgos, F., Casaburi, R., Coates, A., van der Grinten, C. P. M., Gustafsson, P., Hankinson, J., et al. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00035205 · Cited by 5,945 · cited 2×
“•Reference equations for lung function by European Community for Coal and Steel are disputed and limited in predicting lung function in the general population [12].”
BackgroundMethodRabe, K. F., Hurd, S., Anzueto, A., Barnes, P. J., Buist, S. A., Calverley, P., Fukuchi, Y., Jenkins, C., Rodriguez-Roisin, R., van Weel, C., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200703-456so · Cited by 4,925 · cited 4×
“Limitations •There is no standardized definition of an exacerbation, making comparative evaluations of clinical study results difficult [1,66].”
BackgroundInfluentialCelli, B. R., Cote, C. G., Marin, J. M., Casanova, C., Montes de Oca, M., Mendez, R. A., Pinto Plata, V., & Cabral, H. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa021322 · Cited by 4,015 · cited 2×
“Relevance So far the only multidimensional scoring system that has gained broader acceptance is the BODE index which has been developed as a prognostic marker for COPD patients in an attempt to integrate not only the respiratory but also the systemic expressions of COPD in a single grading system [70].”
BackgroundSalmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
Calverley, P. M. A., Anderson, J. A., Celli, B., Ferguson, G. T., Jenkins, C., Jones, P. W., Yates, J. C., & Vestbo, J. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063070 · Cited by 3,248 · cited 3×
“Strengths •All-cause mortality is the most robust and reliable outcome of clinical trials in COPD and is relatively easy to follow-up [4,83,84].”
BackgroundMethodDevelopment and first validation of the COPD Assessment Test
Jones, P. W., Harding, G., Berry, P., Wiklund, I., Chen, W.-H., & Kline Leidy, N. (2009) · European Respiratory Journal · doi:10.1183/09031936.00102509 · Cited by 3,198
Jones, P. W., Quirk, F. H., Baveystock, C. M., & Littlejohns, P. (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/145.6.1321 · Cited by 3,035
Cited by
Goals of COPD treatment: Focus on symptoms and exacerbations
Vogelmeier, C. F., Román-Rodríguez, M., Singh, D., Han, M. K., Rodríguez-Roisin, R., & Ferguson, G. T. (2020) · Respiratory Medicine · doi:10.1016/j.rmed.2020.105938 · Cited by 371
Self-citationKendzerska, T., Mollayeva, T., Gershon, A. S., Leung, R. S., Hawker, G., & Tomlinson, G. (2014) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2013.01.003 · Cited by 265
Waschki, B., Spruit, M. A., Watz, H., Albert, P. S., Shrikrishna, D., Groenen, M., Smith, C., Man, W. D.-C., Tal-Singer, R., Edwards, L. D., et al. (2012) · Respiratory Medicine · doi:10.1016/j.rmed.2011.10.022 · Cited by 170
Home telemonitoring effectiveness in COPD: a systematic review.
Cruz, J., Brooks, D., & Marques, A. (2014) · International Journal of Clinical Practice · doi:10.1111/ijcp.12345 · Cited by 147
Improving physical activity in COPD: towards a new paradigm
Troosters, T., van der Molen, T., Polkey, M., Rabinovich, R. A., Vogiatzis, I., Weisman, I., & Kulich, K. (2013) · Respiratory Research · doi:10.1186/1465-9921-14-115 · Cited by 158
“Accelerometers are electronic devices, generally worn on the arm (multisensory armband devices) or waist, which estimate physical activity outcomes such as body posture, quantity and intensity of body movements, energy expenditure, and physical activity level based on measurements of body’s acceleration [41].”
Background
Metadata
- Authors
- Glaab, T., Vogelmeier, C., & Buhl, R.
- Affiliations
- Johannes Gutenberg University Mainz (DE)
- Universitätsklinikum Gießen und Marburg (DE)
- Corresponding author
- Buhl, Roland
- ORCID
- Glaab, Thomas
- Venue
- Respiratory Research
- Published
- 2010-06-17
- Volume
- 11
- Issue
- 1
- Pages
- 79-79
- ISSN
- 1465-9921 (ISSN-L)
- 1465-993X
- PMC
- PMC2902430
- OpenAlex
- W1998032464
- Cited by
- 130
- References
- 103
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 6 · 2023: 8 · 2022: 2 · 2021: 7 · 2020: 10 · 2019: 9 · 2018: 4 · 2017: 12 · 2016: 9 · 2015: 11 · 2014: 16 · 2013: 10 · 2012: 7
- FWCI
- 1.62
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Respiratory Research (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Keywords
- chronic obstructive pulmonary disease, outcome measures, lung function, health status, exercise capacity, physical activity, dyspnea, COPD exacerbations, BODE index, mortality, clinical trial endpoints
- MeSH terms
- Clinical Trials as Topic, Dyspnea, Exercise Test, Health Status Indicators, Humans, Predictive Value of Tests, Surveys and Questionnaires, Respiratory Function Tests, Severity of Illness Index, Reproducibility of Results, Comorbidity, Treatment Outcome, Exercise Tolerance, Pulmonary Disease, Chronic Obstructive
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Outcome measures in chronic obstructive pulmonary disease (COPD): strengths and limitations. https://app.cochat.ai/papers/10.1186/1465-9921-11-79
- The paper
- Glaab, T., Vogelmeier, C., & Buhl, R. (2010). Outcome measures in chronic obstructive pulmonary disease (COPD): strengths and limitations. Respiratory Research. https://doi.org/10.1186/1465-9921-11-79
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
